申请人:AUTIFONY THERAPEUTICS LIMITED
公开号:US10160730B2
公开(公告)日:2018-12-25
Compounds of formula (I) are of use in the modulation of Kv3.1, Kv.3.2 and Kv3.3 channels and have utility in the treatment or prevention of related disorders.
式(I)化合物可用于调节 Kv3.1、Kv.3.2 和 Kv3.3 通道,并可用于治疗或预防相关疾病。